Memory B cell subsets and plasmablasts are lower in early than in long-standing Rheumatoid Arthritis

BMC Immunology

Volumn 15, Issue 1, 2014, Pages

  Fedele, Anna Laura ^a   Tolusso, Barbara ^a   Gremese, Elisa ^a   Bosello, Silvia Laura ^a   Carbonella, Angela ^a   Canestri, Silvia ^a   Ferraccioli, Gianfranco ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Autoantibodies; B cells; BAFF; IL 6; Rheumatoid arthritis; ZAP 70

Indexed keywords

ADALIMUMAB; B CELL ACTIVATING FACTOR; CD19 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; ETANERCEPT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; INTERLEUKIN 6; METHOTREXATE; PROTEIN KINASE ZAP 70; RHEUMATOID FACTOR; STEROID; LEUKOCYTE ANTIGEN; TNFSF13B PROTEIN, HUMAN; ZAP70 PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; IMMUNOPHENOTYPING; LOW DRUG DOSE; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY CELL; MIDDLE AGED; ONSET AGE; PHENOTYPE; PLASMA CELL; PLASMABLAST; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REMISSION; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; STAINING; STEROID THERAPY; TREATMENT RESPONSE; B LYMPHOCYTE; BLOOD; DEMOGRAPHY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE COUNT; METABOLISM; PATHOLOGY; TIME;

AGE OF ONSET; ANTIGENS, CD; ARTHRITIS, RHEUMATOID; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTE SUBSETS; DEMOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN D; IMMUNOLOGIC MEMORY; INFLAMMATION; INTERLEUKIN-6; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PLASMA CELLS; TIME FACTORS; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 84908090688     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/s12865-014-0028-1     Document Type: Article

References (32)

1. Vencovský J, Machácek S, Sedová L, Kafková J, Gatterová J, Pesáková V, Růzicková S: Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 2003, 62(5):427-430.
2. Machold KP, Stamm TA, Nell VP, Pflugbeil S, Aletaha D, Steiner G, Uffmann M, Smolen JS: Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology (Oxford) 2007, 46(2):342-349.
3. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, Habibuw MR, Vandenbroucke JP, Dijkmans BA: Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004, 50(2):380-386.
4. Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, Rantapää-Dahlqvist S: Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis 2006, 65(4):453-458.
5. Chatzidionysiou K, Lie E, Nasonov E, Lukina G, Hetland ML, Tarp U, Gabay C, van Riel PL, Nordström DC, Gomez-Reino J, Pavelka K, Tomsic M, Kvien TK, van Vollenhoven RF: Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries. Ann Rheum Dis 2011, 70(9):1575-1580.
6. Marston B, Palanichamy A, Anolik JH: B cells in the pathogenesis and treatment of rheumatoid arthritis. Curr Opin Rheumatol 2010, 22(3):307-315.
7. Silverman GJ, Boyle DL: Understanding the mechanistic basis in rheumatoid arthritis for clinical response to anti-CD20 therapy: the B cell roadblock hypothesis. Immunol Rev 2008, 223:175-185.
8. Gottenberg JE, Miceli-Richard C, Ducot B, Goupille P, Combe B, Mariette X: Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort. Arthritis Res Ther 2009, 11(4):R114.
9. Bosello S, Youinou P, Daridon C, Tolusso B, Bendaoud B, Pietrapertosa D, Morelli A, Ferraccioli G: Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis. J Rheumatol 2008, 35(7):1256-1264.
10. Fekete A, Soos L, Szekanecz Z, Szabo Z, Szodoray P, Barath S, Lakos G: Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses. J Autoimmun 2007, 29(2-3):154-163.
11. Souto-Carneiro MM, Mahadevan V, Takada K, Fritsch-Stork R, Nanki T, Brown M, Fleisher TA, Wilson M, Goldbach-Mansky R, Lipsky PE: Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor. Arthritis Res Ther 2009, 11(3):R84.
12. Gremese E, Salaffi F, Bosello SL, Ciapetti A, Bobbio-Pallavicini F, Caporali R, Ferraccioli G: Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study. Ann Rheum Dis 2013, 72(6):858-862.
13. Moura RA, Weinmann P, Pereira PA, Caetano-Lopes J, Canhão H, Sousa E, Mourão AF, Rodrigues AM, Queiroz MV, Souto-Carneiro MM, Graça L, Fonseca JE: Alterations on peripheral blood B-cell subpopulations in very early arthritis patients. Rheumatology (Oxford) 2010, 49(6):1082-1092.
14. Tolusso B, De Santis M, Bosello S, Gremese E, Gobessi S, Cuoghi I, Totaro MC, Bigotti G, Rumi C, Efremov DG, Ferraccioli G: Synovial B cells of rheumatoid arthritis express ZAP-70 which increases the survival and correlates with the inflammatory and autoimmune phenotype. Clin Immunol 2009, 131(1):98-108.
15. Klasen C, Ohl K, Sternkopf M, Shachar I, Schmitz C, Heussen N: MIF Promotes B Cell Chemotaxis through the Receptors CXCR4 and CD74 and ZAP-70 Signaling. J Immunol 2014, 192(11):5273-5284.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31(3):315-324.
17. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, et al: 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010, 62(9):2569-2581.
18. Bosello S, Fedele AL, Peluso G, Gremese E, Tolusso B, Ferraccioli G: Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progression. Ann Rheum Dis 2011, 70(7):1292-1295.
19. Fransen J, van Riel PL: The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol 2005, 23(5 Suppl 39):S93-S99.
20. van Gestel AM, Prevoo ML, van't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL: Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996, 39(1):34-40.
21. Prevoo ML, van Gestel AM, van T Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL: Remission in a prospective study of patients with rheumatoid arthritis: American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol 1996, 35(11):1101-1105.
22. Aletaha D, Smolen J: The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005, 23(5 Suppl 39):S100-S108.
23. Sanz I, Wei C, Lee FE, Anolik J: Phenotypic and functional heterogeneity of human memory B cells. Semin Immunol 2008, 20(1):67-82.
24. Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marcé S, López-Guillermo A, Campo E, Montserrat E: ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003, 348(18):1764-1775.
25. Michelutti A, Gremese E, Morassi F, Petricca L, Arena V, Tolusso B, Alivernini S, Peluso G, Bosello SL, Ferraccioli G: B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. Mol Med 2011, 17(9-10):901-909.
26. Duty JA, Szodoray P, Zheng NY, Koelsch KA, Zhang Q, Swiatkowski M, Mathias M, Garman L, Helms C, Nakken B, Smith K, Farris AD, Wilson PC: Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors. J Exp Med 2009, 206(1):139-151.
27. Kamburova EG, Koenen HJ, Boon L, Hilbrands LB, Joosten I: In vitro effects of rituximab on the proliferation, activation and differentiation of human B cells. Am J Transplant 2012, 12(2):341-350.
28. Wei C, Anolik J, Cappione A, Zheng B, Pugh-Bernard A, Brooks J, Lee EH, Milner EC, Sanz I: A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol 2007, 178(10):6624-6633.
29. Moura RA, Cascão R, Perpétuo I, Canhão H, Vieira-Sousa E, Mourão AF, Rodrigues AM, Polido-Pereira J, Queiroz MV, Rosário HS, Souto-Carneiro MM, Graca L, Fonseca JE: Cytokine pattern in very early rheumatoid arthritis favours B cell activation and survival. Rheumatology (Oxford) 2011, 50(2):278-282.
30. Kokkonen H, Söderström I, Rocklöv J, Hallmans G, Lejon K, Rantapää Dahlqvist S: Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum 2010, 62(2):383-391.
31. Ferraccioli G, Bracci-Laudiero L, Alivernini S, Gremese E, Tolusso B, De Benedetti F: Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis. Mol Med 2010, 16(11-12):552-557.
32. Gremese E, Tolusso B, Fedele AL, Canestri S, Alivernini S, Ferraccioli G: Baseline ZAP-70+ B cell subset influences response to B-cell depletion therapy (BCDT) and early repopulation in Rheumatoid Arthritis. J Rheumatol 2012, 39(12):2276-2285.